- Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma
Andrea Gaißler et al, 2023, Journal for ImmunoTherapy of Cancer CrossRef - Latest evidence on clinical outcomes and prognostic factors of advanced urothelial carcinoma in the era of immune checkpoint inhibitors: a narrative review
Satoru Taguchi et al, 2024, Japanese Journal of Clinical Oncology CrossRef